Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Shekhtman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Physical Review. E|March 15, 2020
Interconnections between networks acting like an external field in a first-order percolation transitionBnaya Gross, Hillel Sanhedrai, Louis Shekhtman, et al.
Journal of Hepatology|January 7, 2022
Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulationLouis Shekhtman, Scott J Cotler, Alexander Ploss, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|September 7, 2017
High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network MembersBasmattee Boodram, Anna L Hotton, Louis Shekhtman, et al.
Current Gastroenterology Reports|October 11, 2023
Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral TreatmentsLouis Shekhtman, Sarah Duehren, Ohad Etzion, et al.
Viruses|January 23, 2020
Modeling Challenges of Ebola Virus-Host Dynamics during Infection and TreatmentDaniel S Chertow, Louis Shekhtman, Yoav Lurie, et al.
National Science Review|October 25, 2021
Predictability of real temporal networksDisheng Tang, Wenbo Du, Louis Shekhtman, et al.
Plos One|July 26, 2017
Debunking in a world of tribesFabiana Zollo, Alessandro Bessi, Michela Del Vicario, et al.
Hepatology Communications|July 17, 2023
Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cureLeeor Hershkovich, Louis Shekhtman, Michel Bazinet, et al.
Antiviral Research|December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cureLeeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
Open Forum Infectious Diseases|June 15, 2026
Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject DrugsEric Tatara, Louis Shekhtman, Nicholson Collier, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Physical Review. E|March 15, 2020
Interconnections between networks acting like an external field in a first-order percolation transitionBnaya Gross, Hillel Sanhedrai, Louis Shekhtman, et al.
Journal of Hepatology|January 7, 2022
Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulationLouis Shekhtman, Scott J Cotler, Alexander Ploss, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|September 7, 2017
High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network MembersBasmattee Boodram, Anna L Hotton, Louis Shekhtman, et al.
Current Gastroenterology Reports|October 11, 2023
Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral TreatmentsLouis Shekhtman, Sarah Duehren, Ohad Etzion, et al.
Viruses|January 23, 2020
Modeling Challenges of Ebola Virus-Host Dynamics during Infection and TreatmentDaniel S Chertow, Louis Shekhtman, Yoav Lurie, et al.
National Science Review|October 25, 2021
Predictability of real temporal networksDisheng Tang, Wenbo Du, Louis Shekhtman, et al.
Plos One|July 26, 2017
Debunking in a world of tribesFabiana Zollo, Alessandro Bessi, Michela Del Vicario, et al.
Hepatology Communications|July 17, 2023
Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cureLeeor Hershkovich, Louis Shekhtman, Michel Bazinet, et al.
Antiviral Research|December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cureLeeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
Open Forum Infectious Diseases|June 15, 2026
Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject DrugsEric Tatara, Louis Shekhtman, Nicholson Collier, et al.
Pageof 3